Statement Of Financial Position [Abstract]

Hyloris Pharmaceuticals SA - Filing #5880974

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	—	—	—	340,000 EUR	429,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	—	—	—	3,838,000 EUR	3,828,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Investments accounted for using equity method	—	—	—	—	—	—	2,748,000 EUR	3,801,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	—	—	—	23,594,000 EUR	30,406,000 EUR	—	—	—	—	—	—	33,457,000 EUR	—	—	—	—	—	—
Assets	—	—	—	—	—	—	41,335,000 EUR	47,681,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	—	—	—	140,000 EUR	140,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Share premium	—	—	—	—	—	—	121,513,000 EUR	121,513,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Other reserves	—	—	—	—	—	—	476,000 EUR	476,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	86,471,000 EUR	121,513,000 EUR	140,000 EUR	476,000 EUR	945,000 EUR	4,460,000 EUR	32,143,000 EUR	39,069,000 EUR	80,761,000 EUR	476,000 EUR	121,513,000 EUR	140,000 EUR	2,162,000 EUR	4,460,000 EUR	53,909,000 EUR	476,000 EUR	121,513,000 EUR	1,622,000 EUR	65,381,000 EUR	140,000 EUR	4,460,000 EUR
Liabilities [abstract]
Liabilities	—	—	—	—	—	—	9,192,000 EUR	8,613,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	—	—	—	—	—	41,335,000 EUR	47,681,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—